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Abstract Cytochrome c (cyt c) release was investigated in
cerebellar granule cells used as an in vitro neuronal model of
apoptosis. We have found that cyt c is released into the
cytoplasm as an intact, functionally active protein, that this
event occurs early, in the commitment phase of the apoptotic
process, and that after accumulation, this protein is progressively
degraded. Degradation, but not release, is fully blocked by
benzyloxycarbonyl-Val-Ala-Asp-fluoromethylchetone (z-VAD-
fmk). On the basis of previous findings obtained in the same
neuronal population undergoing excitotoxic death, it is hypothe-
sized that release of cyt c may be part of a cellular attempt to
maintain production of ATP via cytochrome oxidase, which is
reduced by cytosolic NADH in a cytochrome b5-soluble cyt
c-mediated fashion.
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1. Introduction
In vitro cultured cerebellar granule cells (CGCs) undergo a
massive process of apoptosis when the extracellular concen-
tration of KCl employed for their culturing (25 mM) is shifted
to 5 mM. KCl-triggered apoptosis of CGCs is characterized
by DNA fragmentation [1], TUNEL positivity and formation
of apoptotic bodies [2] and is attributed to an intracellular
Ca2 drop [3]. The apoptotic process is inhibited by transcrip-
tional and translational inhibitors, by IGF-I, forskolin, cAMP
[1], as well as by neurotransmitters and neuromodulators such
as ADP and adenosine [2]. This peculiar neuronal response,
characterized by activation of apoptosis following membrane
repolarization, has been hypothesized as an in vitro response
that could mimic an in vivo prolonged state of neuronal de-
polarization [1,3].
Among the intracellular organelles and structures involved
in the apoptotic process of CGCs, mitochondria appear to be
particularly involved since their ability to produce ATP via
oxidative phosphorylation is already 50% reduced 2 h after
the apoptotic trigger [4]. A further involvement of mitochon-
dria in apoptosis has recently been pointed out by the ¢nding
that one of the constituents of the respiratory chain, cyto-
chrome c (cyt c), is released from mitochondria into the cy-
tosol of several cell types [5,6]. A similar cytosolic accumula-
tion has also been reported in CGCs treated with the
neurotoxin 1-methyl-4-phenylpyridinium [7] or with the anti-
microtubular agent colchicine [8].
Although the presence of cyt c in the cytoplasmic compart-
ment of several cell types undergoing apoptosis constitutes a
frequent ¢nding, nothing is known about the mechanism(s)
that causes such an unpredictable event, the fate of this pro-
tein once released into the cytoplasm and its possible biolog-
ical signi¢cance, whether as a side e¡ect of the mitochondrial
functional impairment, a cellular attempt to cope with the
destructive apoptotic message or part of the pathway eventu-
ally leading to cell death.
In order to investigate some of these questions, we selected
the in vitro model of CGCs because, to our knowledge, they
constitute the most suitable in vitro model of primary neuro-
nal cultures whereby such a programmed death can be ana-
lyzed. Moreover, the possibility of inducing apoptosis by a
relatively physiological manipulation, consisting of repolariz-
ing the membrane potential via the KCl shift from 25 to
5 mM, provides a mechanism by far less drastic than that
of using toxic [7] or other harmful manipulations [8] that do
not mimic a possible in vivo situation. It will be shown that
cyt c is released by mitochondria as a very early event and
that after a progressive accumulation, it is degraded by the
speci¢c apoptotic pathway of cytosolic caspases.
2. Materials and methods
2.1. Reagents
Anti-cyt c antibodies (7H8-2C12) were purchased from Pharmingen
(San Diego, CA, USA). Anti-glutamate dehydrogenase (GDH) anti-
bodies were kindly supplied by Dr F. Rothe (Institut fur Medizinische
Neurobiologie, University of Magdeburg, Magdeburg, Germany).
Anti-cytochrome oxidase (subunit IV) antibodies (20E8-C12) were
purchased from Molecular Probes (Eugene, OR, USA). Peroxidase-
conjugated anti-mouse and anti-rabbit antibodies were from Amer-
sham. Cycloheximide and actinomycin D were from Sigma Chemical
(St. Louis, MO, USA). Benzyloxycarbonyl-Val-Ala-Asp-£uoromethyl-
chetone (z-VAD-fmk) was obtained from Calbiochem (La Jolla, CA,
USA).
2.2. Cell cultures
Primary cultures of cerebellar granule neurons were obtained as
described in [9]. Before each experiment, both the cell viability and
integrity were analyzed as already reported in [10]. Cell homogenates
from a cell suspension were obtained with 20 strokes performed in a
Dounce potter at room temperature. The integrity of mitochondria in
the homogenate was assessed by measuring the activities of both ad-
enylate kinase (ADK, E.C. 2.7.4.3) and GDH (E.C. 1.4.1.3), which
are marker enzymes of the mitochondrial intermembrane space and
matrix, respectively. The percentage of damaged mitochondria was
lower than 1.5%. Mitochondrial coupling, which re£ects the ability
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of mitochondria to produce ATP, was evaluated as in [4,11]. The cell
protein content was determined according to Waddel and Hill [12],
with bovine serum albumin as a standard.
2.3. Induction of apoptosis
Apoptosis was induced as previously reported [1]. At 6^7 DIV, cells
were washed twice and switched to a serum-free basal medium with
Eagle’s salts (BME), containing 5 mM KCl (S-K5), and supplemented
with 2 mM glutamine and 100 Wg/ml gentamicin, for the time reported
in the ¢gure legends. Controls were treated identically but maintained
in serum-free BME medium supplemented with 25 mM KCl (S-K25).
Cell death due to apoptosis was evaluated 24 h after the shift of [K]
by counting viable cells, according to Volonte' et al. [13]. Inhibitors
were added to the cells simultaneously with the [K] shift, unless
otherwise stated, with the ¢nal concentration of DMSO kept below
0.1%. Corresponding controls were treated with the same concentra-
tion of DMSO.
2.4. Immunoblot analysis
Immunoblot analysis was performed on cytosolic and mitochon-
drial extracts from control and apoptotic cultures. In both cases, cells
were washed once with phosphate-bu¡ered saline (PBS) and collected
by centrifugation at 2000Ug for 5 min at 4‡C. The cell pellet was
resuspended in 500 Wl of extraction bu¡er containing 250 mM sucrose,
50 mM Tris-HCl, 1 mM EGTA, 1 mM EDTA, 1 mM DTT, 1 mM
1,10-phenantroline, 0.1 mM PMSF pH 7.4. The cells were homogen-
ized in a Te£on/glass homogenizer (10 strokes) and after 5 min on ice,
the suspension was centrifuged at 15 000Ug for 30 min. The super-
natants (i.e. cytosolic fractions) were removed and stored at 380‡C
until analyzed by gel electrophoresis. The pellets were resuspended in
500 Wl of 20 mM Tris-HCl, 1 mM EDTA, 1 mM EGTA, 1 M DTT,
1 mM 1,10-phenantroline, 0.1 mM PMSF pH 7.4 and homogenized
on ice (10 strokes). After centrifugation at 750Ug for 10 min at 4‡C
to pellet nuclei, 400 Wl of the resulting supernatant was supplemented
with 400 mM NaCl and 1% Triton X-100. After 5 min incubation on
ice, the samples were centrifuged at 15 000Ug for 5 min at 4‡C to
remove insoluble materials. Supernatants, corresponding to the solu-
bilized mitochondrial fraction, were aliquoted and stored at 380‡C.
10 Wg of either cytosolic or mitochondrial proteins was loaded onto a
15% SDS-polyacrylamide gel, separated and transferred to a PVDF
membrane which was probed with the di¡erent antibodies. Immuno-
blot analysis was performed with horseradish peroxidase-conjugated
anti-mouse or anti-rabbit antibodies using enhanced chemilumines-
cence Western blotting reagents (Amersham). Relative optical den-
sities and areas of bands were quanti¢ed using the GS-700 Imaging
Densitometer implemented with Molecular Analyst Software (Bio-
Rad).
2.5. Oxygen uptake studies
O2 consumption was measured polarographically at 37‡C, as in
[4,10,11], by means of a Gilson 5/6 oxygraph, using a Clark electrode.
The instrument sensitivity was set to a value which allowed us to
follow rates of O2 uptake as low as 0.5 natoms/min/mg protein.
2.6. ADK and GDH assay
ADK activity was measured photometrically at 37‡C essentially as
reported in [14] in the presence of 0.2 Wg of oligomycin plus 1 WM
atractyloside. GDH activity was assayed photometrically at 37‡C es-
sentially as described in [15]. Given that no signi¢cant activity was
usually measured owing to the integrity of the mitochondria, a further
check was made in Triton X-100-treated cell homogenate.
3. Results
Cyt c release from mitochondria was investigated by check-
ing its presence in the cytosolic fractions of apoptotic CGCs
(S-K5) by protein immunoblot analysis. In order to exclude
the presence of intact mitochondria in the cytosolic fractions,
Fig. 1. Western blot analysis of cyt c. (A) Cytosolic fractions from either control (S-K25) or apoptotic (S-K5) CGCs were obtained at 0.5, 1.5,
3, 8, 15 and 24 h as indicated, after serum and potassium removal and analyzed by Western blotting analysis as described in Section 2. (B)
The cytosolic content of cyt c was quanti¢ed by densitometric scanning of the ¢lm and expressed, after normalization, as a percentage of con-
trol cells (S-K25), where control cells were analyzed at the di¡erent times and to which a value of 100 has been given. (C) Mitochondrial frac-
tions from either control (S-K25) or apoptotic (S-K5) CGCs were obtained at 0.5, 1.5, 3, 8, 15 and 24 h as indicated, after serum and potassi-
um removal and analyzed by Western blotting analysis as described in Section 2. Antibodies against GDH were used to normalize the protein
amount loaded onto the gel. (D) The amount of cyt c was quanti¢ed by densitometric scanning of the ¢lm and expressed as a percentage of
control cells (S-K25), where control cells were analyzed at the di¡erent times and to which a value of 100 has been given. Results are
means þ S.D. of triplicate measurements and representatives of at least 10 di¡erent experiments carried out with di¡erent cell preparations pre-
pared from di¡erent groups of animals.
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¢lters were probed with monoclonal antibodies against cyto-
chrome oxidase (subunit IV) (not shown). Moreover, in order
to account for possible cyt c release due to mitochondrial
damage occurring during the cell fractionation procedure,
the same ¢lter was probed with a polyclonal antibody against
GDH, a marker enzyme of the mitochondrial matrix. A typ-
ical experiment is reported in Fig. 1A with the densitometric
analysis of several experiments of both the cyt c and the GDH
blots shown in Fig. 1B. The GDH amount in each lane was
used to normalize the corresponding amount of cyt c revealed
on the same ¢lter. Cyt c is already detectable in the cytosolic
fraction 30 min after apoptosis induction, its amount reaches
a maximum after 3 h with a 238 þ 36% increment over con-
trols and declines thereafter, being roughly similar to that
measured in controls after 24 h.
The amount of cyt c in the corresponding mitochondrial
fractions, evaluated in the same cellular preparation, is re-
ported in Fig. 1C and D. An early decrease in the amount
of mitochondrial cyt c occurs in the ¢rst 30 min, reaches a
minimum after 3 h and remains constantly low in the follow-
ing 24 h.
In order to ascertain whether the cyt c released into the
Table 1
Detection of both ADK and GDH in the cytosolic fraction and cell homogenate of CGCs undergoing apoptosis
Enzymatic activity S-K25 S-K5
Cytosolic fraction Homogenate+TX-100 Cytosolic fraction Homogenate+TX-100
ADK 0.14 þ 0.08 40 þ 2.2 0.5 þ 0.06 41 þ 1.9
GDH 1.8 þ 0.33 421 þ 20 2.1 þ 0.41 430 þ 22
Either the cytosolic fraction or the homogenate in the presence of Triton X-100 (TX-100, 0.5%) from control (S-K25) or CGCs undergoing
apoptosis (S-K5) (about 0.2 mg protein) were incubated at 37‡C in 1.5 ml PBS and assayed, at 3 h after apoptotic stimulus, for both ADK
and GDH activity, as reported in Section 2. Enzymatic activity is expressed as nmol NADP reduced (NADH oxidized)/min/mg cell protein
for ADK and GDH, respectively. The values of 10 enzymatic activities ( þ S.E.M.) obtained from six experiments, carried out by using di¡erent
cell preparations, are reported.
Fig. 2. Released cyt c is functionally active. CGCs were switched from high K (S-K25) to low K (S-K5) serum-free culture medium for the
indicated times, subsequently collected, suspended in PBS and homogenized (see text for details). Aliquots (about 0.2 mg protein) were incu-
bated in the presence of rotenone (3 WM), antimycin A (0.8 WM) and myxothiazole (6 WM) at 37‡C in a water-jacketed glass vessel to monitor
O2 consumption polarographically. (A) S-K5 neurons at 30 min (a), 3 h (c) and 15 h (e) after apoptosis induction or the corresponding S-K25
neurons (b, d and f) were used. The following additions were made: ASC (5 mM), TMPD (0.2 mM), cyanide (CN3, 1 mM). (B) S-K5 neurons
at 30 min were used. The following additions were made: ASC (5 mM), FCCP (0.01 WM), ADP (1 mM). Numbers along the traces are rates
of oxygen uptake expressed as natoms O2/min/mg cell protein. In ¢ve experiments, carried out using di¡erent cell preparations, variations up
to 5% were found. (C) The dependence of the ascorbate-dependent oxygen uptake rate versus the duration of low K treatment was studied
for control (a) and low K CGCs (b), as reported above. The initial rate of the reaction was expressed as natoms O2/min/mg cell protein. Re-
sults are means þ S.D. of triplicate measurements and representatives of at least ¢ve di¡erent experiments carried out with di¡erent cell prepara-
tions prepared from di¡erent groups of animals.
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cytosol is fully functional, the rate of ascorbate-dependent
oxygen consumption in the absence of N,N,NP,NP-tetrameth-
yl-p-phenylenediamine (TMPD) (Fig. 2) was measured polaro-
graphically in CGC homogenate, essentially as reported in
[10]. S-K25 and S-K5 cells were compared with respect to
their capability to oxidize ascorbate (5 mM). The rate of oxy-
gen uptake increases from about four to 10 natoms O2/min/
mg cell protein 30 min after the start of apoptotic treatment
(Fig. 2A, a and b). In both cases, the externally added TMPD
(0.2 mM) was found to strongly stimulate the rate of oxygen
uptake. Cyanide, a classic inhibitor of mitochondrial cyto-
chrome oxidase activity, completely prevents oxygen con-
sumption. To verify that the release of cyt c takes place
from intact mitochondria, in the same experiment, the activity
of the mitochondrial ADK and GDH was assayed in either
control or cells undergoing apoptosis (Table 1). Neither di¡er-
ence in the ADK activity, measured in S-K25 and S-K5, was
found as judged by a statistical analysis (Ps 0.1) nor signi¢-
cant activity was present in the respective supernatants, i.e.
cytosolic fraction, without Triton X-100 addition (not shown).
The intactness of the mitochondrial inner membrane was also
checked by assaying GDH, which is a marker of the mito-
chondrial matrix. A negligible GDH activity was found both
in cell homogenate and in the cytosolic fraction, whereas its
activity has been proved (Ps 0.3) following treatment of cells
with Triton X-100. Moreover, in order to verify mitochondrial
coupling, FCCP and ADP were added to S-K25 and S-K5
cells (Fig. 2B) as in [11]. Both of them proved to stimulate
the rate of oxygen consumption with ICR values equal to
about three and two, respectively.
The percentage increase in the rate of oxygen uptake caused
by ascorbate addition to either apoptotic or control CGCs as
a function of the apoptotic treatment time is reported in Fig.
2C. Interestingly, a few min (30) of low [K] exposure causes
a remarkable increase in the ascorbate-dependent oxygen up-
take rate with respect to control cultures, indicating the pres-
ence of a pool of soluble cyt c. Further stimulation was found
up to 3 h after the switch to low [K+] (35 natoms O2/min/mg
cell protein) (Fig. 2A, c and d). Similarly to the ¢nding re-
ported in Fig. 1, a signi¢cant decline in the rate of oxygen
uptake, i.e. in the amount of fully functional cyt c, was found
in the following 3^24 h range (Fig. 2A, e and f) after the
apoptosis trigger.
When both S-K5 and S-K25 cells were incubated in the
presence of inhibitors of transcription and translation such
as actinomycin D (1 Wg/ml) and cycloheximide (10 Wg/ml),
respectively, as well as growth factors such as IGF-I (25 ng/
ml), which have previously been reported to inhibit apoptosis
in CGCs to a varying extent [1], neither cyt c protein nor cyt c
activity was detected in the extramitochondrial phase, clearly
showing that these compounds can prevent cyt c release and
that this release is speci¢cally associated with the apoptotic
process (not shown).
Since a link between cyt c release and the activity of cas-
pases has been reported [16], experiments were carried out to
investigate the possible involvement of this class of proteases
in early cyt c release from mitochondria and in the subsequent
cellular decrease observed in this study. Thus, z-VAD-fmk
(100 WM), a broad-range speci¢c caspase inhibitor (for review,
see Cohen et al. [17]), was added to CGCs during apoptotic
treatment (Table 2) under two experimental conditions: con-
temporarily with the shift to low [K] (line 4) corresponding
to the commitment phase of apoptosis [3] or after 3 h (lines 6^
8), i.e. when cyt c is apparently on its route of degradation.
Cyt c activity was followed as above. In the ¢rst type of
experiments, cyt c activity was detected in the cytosol (line
4) with no signi¢cant change compared to that found in apop-
totic CGCs in the absence of the caspase inhibitor (line 2).
Interestingly, no decrease in cyt c content was found in the 3^
24 h range of apoptosis if the inhibitor was added to the plate
3 h after the induction of apoptosis (lines 6^8), thus showing
that z-VAD-fmk has no e¡ect on the release of cyt c, but it
can prevent long term cyt c degradation.
4. Discussion
In this paper, evidence is given that apoptosis of CGCs
cultured in low potassium medium is accompanied by release
of cyt c, which starts to accumulate in the cytosol at a very
early stage with the maximum accumulation reached after 3 h.
Cyt c release is shown in this paper both via immunoblotting
and via polarographic experiments which have the added di-
mension to show that the released cyt c is fully functional. The
time courses of the cyt c level both in the cytosolic and in the
mitochondrial fractions deserve special discussion. Indeed, in
the ¢rst 3 h of treatment, the increase in the extramitochon-
drial phase and the decrease in the mitochondria appear to be
correlated. However, a clear di¡erence is found after a long
term treatment when the cyt c amount remains constant in the
mitochondria, even though at a concentration lower than in
Table 2
E¡ect of z-VAD-fmk on cyt c release from CGCs undergoing apoptosis as measured polarographically
Line Treatment Oxygen consumption rate (natoms O2/min/mg cell protein)
t = 0 t+3 h t+8 h t+18 h
1 S-K25S 4.5 þ 0.1
2 S-K5 34.4 þ 4.4 17.7 þ 1.8 12.1 þ 1.5
3 S-K25+DMSO 4.4 þ 0.3
4 S-K5+z-VAD-fmk 35.5 þ 4.8
5 S-K25 +DMSO 4.8 þ 0.3
6 S-K5 +z-VAD-fmk 32.7 þ 3.9
7 S-K25 +DMSO 5.2 þ 0.1
8 S-K5 +z-VAD-fmk 36.2 þ 3.9
Homogenates from either control (S-K25) or CGCs undergoing apoptosis (S-K5) (about 0.4 mg protein) were incubated at 37‡C in 1.5 ml PBS
in the presence of rotenone (3 WM), antimycin A (0.8 WM) and myxothiazole (6 WM). Experimental conditions as reported in Fig. 2. Addition
of z-VAD-fmk (100 WM) was done at the indicated times. Oxygen consumption after addition of ascorbate (5 mM) was recorded in each test
and the initial rate of the reaction is expressed as natoms O2/min/mg cell protein. In ¢ve experiments, carried out using di¡erent cell prepara-
tions, variations up to 5% were found.
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controls, but it strongly decreases in the cytosol. A corre-
spondent decrease in the activity of cyt c was also detected.
These experimental ¢ndings show that cyt c is released during
the phase of apoptotic commitment and is degraded during
the execution phase. Such a conclusion is consistent with z-
VAD-fmk experiments which give clear experimental evidence
that cyt c release is not mediated by caspases, since it is not
blocked by z-VAD-fmk as also detected in other cell systems
[5,18], although this inhibitor largely blocks the apoptotic
process [19]. On the other hand, z-VAD-fmk clearly inhibited
the later decrease in both cyt c content and activity once
administered at the time when the cytoplasmic cyt c level
reached its maximum (i.e. 3 h). This ¢nding indicates for
the ¢rst time that cyt c is degraded in a caspase-dependent
way. It should be noted that di¡erent results have recently
been reported in studies carried out with a di¡erent neuronal
cell type [18].
Previous studies performed on CGCs undergoing necrotic
death upon exposure to glutamate [10] revealed that cyt c was
released from mitochondria and participates in the oxidation
of cytosolic NADH via NADH-b5 oxidoreductase. In the
light of this report and concerning the possible functional
signi¢cance of cyt c release during the apoptotic process,
our ¢ndings are in favor of the proposal that the early release
could contribute, via NADH-b5 oxidoreductase, to the main-
tenance of adequate cell ATP [20], which, in turn, could play a
role in the cellular integrity or, alternatively, in the execution
phase of the apoptotic program. Concomitantly, cyt c could
also initiate the caspase cascade as proposed by [5,16] and
con¢rmed by the ¢nding that CPP32-like protease activity
only starts to increase in apoptotic CGCs after 3 h from the
administration of an apoptotic stimulus (i.e. after cytosolic cyt
c has reached its maximum level).
The picture that emerges from the experimental ¢ndings
reported in this paper is one in which the cyt c level in the
cytosol is controlled by (i) the cytosolic cyt c increase due to
its release from mitochondria and (ii) its decrease due to its
degradation. A system including a controlled cyt c level will
be much more sensitive to any regulatory e¡ects than a system
lacking the degradation step.
The leak of cyt c from mitochondria and its release into the
cytosol may play a pivotal role in the regulation of the pro-
grammed cell death pathways in CGCs. At present, the mech-
anism by which cyt c release occurs remains to be established.
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